Analysis of biosimilar naming policy of WHO and national regulatory authorities

REN Yue-ming

Chinese Journal of Pharmaceutical Analysis ›› 2014, Vol. 34 ›› Issue (6) : 952-957.

Chinese Journal of Pharmaceutical Analysis ›› 2014, Vol. 34 ›› Issue (6) : 952-957.

Analysis of biosimilar naming policy of WHO and national regulatory authorities

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2014, 34(6): 952-957

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Journal of Pharmaceutical Analysis, All Rights Reserved.
E-mail：ywfx@nifdc.org.cn
Powered by Beijing Magtech Co. Ltd.

/

〈 〉